# SLC37A1

## Overview
SLC37A1 is a gene that encodes the protein solute carrier family 37 member 1, which is a transmembrane transporter involved in the phosphate-linked antiport of glucose-6-phosphate. This protein is primarily localized in the endoplasmic reticulum (ER) membrane and is characterized by its complex structure, which includes 10-12 transmembrane domains (Cappello2018The). The SLC37A1 protein is hypothesized to function as a glycerol-3-phosphate exchanger, although this activity has not been experimentally confirmed (Cappello2018The). It shares sequence homology with bacterial glycerol-3-phosphate permeases, suggesting a similar transport mechanism (Iacopetta2009SLC37A1). The gene is expressed in various tissues, with notable expression in the intestine, pancreas, and neutrophils, indicating its potential role in these cells (Cappello2018The). SLC37A1 has been implicated in cancer progression, particularly in colorectal and breast cancers, where its expression is upregulated, suggesting its potential as a prognostic biomarker and therapeutic target (Kikuchi2017Upregulated; Iacopetta2009SLC37A1).

## Structure
The SLC37A1 protein, encoded by the SLC37A1 gene, is a member of the solute carrier family 37 and is involved in phosphate-linked antiport of glucose-6-phosphate. It consists of 533 amino acids and has a molecular weight of approximately 58 kDa (Cappello2018The). The protein is predicted to have a complex structure with 10-12 transmembrane domains, characteristic of its role as a transmembrane transporter (Cappello2018The). These transmembrane domains likely form alpha-helices, which are common in the secondary structure of membrane proteins.

The SLC37A1 protein contains a mitochondrial cleavage site and both N- and C-terminal signals for endoplasmic reticulum (ER) retention, indicating its localization and potential functional roles within the ER (Cappello2018The). It shares sequence homology with bacterial glycerol-3-phosphate permeases, suggesting a similar transport mechanism (Cappello2018The). The protein is 86% identical to its mouse homolog, highlighting its evolutionary conservation (Cappello2018The).

Post-translational modifications such as phosphorylation may influence the activity and localization of SLC37A1, although specific modifications have not been detailed in the provided context. The protein's structure supports its hypothesized function as a glycerol-3-phosphate exchanger, although this activity has not been experimentally confirmed (Cappello2018The).

## Function
The SLC37A1 gene encodes a protein that is part of the solute carrier family 37, which is involved in the transport of metabolites across biological membranes. SLC37A1 is primarily localized in the endoplasmic reticulum (ER) membrane and functions as a phosphate-linked antiporter, facilitating the exchange of glucose-6-phosphate (G6P) and inorganic phosphate (Pi) (Cappello2018The). It is hypothesized to transport glycerol-3-phosphate (G3P) and may play a role in glycolipid metabolism, although this activity has not been conclusively demonstrated (Cappello2018The). The protein shares sequence homology with bacterial glycerol-3-phosphate transporters, suggesting it may function similarly as an antiporter (Iacopetta2009SLC37A1).

SLC37A1 is expressed in various tissues, with higher levels observed in the intestine, pancreas, and neutrophils, indicating a potential role in these cells (Cappello2018The). While its specific function in healthy human cells is not fully understood, its involvement in phospholipid biosynthesis suggests a role in normal cellular lipid metabolism (Iacopetta2009SLC37A1). The protein's activity is crucial for maintaining cellular energy balance and metabolic processes.

## Clinical Significance
The SLC37A1 gene is associated with various cancers, particularly colorectal and breast cancer, due to its altered expression levels. In colorectal cancer (CRC), SLC37A1 expression is significantly upregulated in tumor tissues compared to non-tumor tissues. This upregulation is linked to poor patient outcomes, including venous invasion, liver metastasis, and reduced overall survival time, suggesting its potential as a prognostic biomarker for CRC progression and metastasis (Kikuchi2017Upregulated). In breast cancer, SLC37A1 expression is upregulated by epidermal growth factor (EGF) in ER-negative breast cancer cells, indicating a role in lipid metabolism alterations observed in cancer cells (Iacopetta2009SLC37A1).

The gene's involvement in cancer is thought to be related to its role in glycolipid metabolism and phospholipid biosynthesis, as it may function as a glycerol-3-phosphate exchanger (Cappello2018The). Despite its expression in various tissues, including the kidney, liver, and spleen, the physiological role of SLC37A1 remains unclear, and no specific diseases or conditions have been directly linked to mutations in the gene (Cappello2018The). However, its upregulation in cancer cells highlights its potential significance in cancer progression and as a therapeutic target.

## Interactions
The SLC37A1 protein, a member of the solute carrier family, functions as a phosphate-linked glucose-6-phosphate (G6P) antiporter associated with the endoplasmic reticulum (ER). Despite its role in G6P transport, SLC37A1 does not couple with glucose-6-phosphatase-a (G6Pase-a) or G6Pase-b, which are essential for hydrolyzing G6P into glucose and phosphate, a process crucial for blood glucose homeostasis (Pan2011SLC37A1). This lack of coupling suggests that SLC37A1 operates independently of the G6Pase system, unlike its family member SLC37A4, which is functionally coupled with G6Pase enzymes (Pan2011SLC37A1).

SLC37A1's expression is upregulated by epidermal growth factor (EGF) in certain cancer cells, indicating a potential role in phospholipid biosynthesis and cancer progression (Iacopetta2009SLC37A1). However, specific protein interactions involving SLC37A1, such as forming multiprotein complexes or engaging in regulatory interactions, have not been detailed in the available studies (Kikuchi2017Upregulated; Iacopetta2009SLC37A1). The protein's exact interactions and functional roles remain an area for further research.


## References


[1. (Kikuchi2017Upregulated) Daiki Kikuchi, Motonobu Saito, Katsuharu Saito, Yohei Watanabe, Yoshiko Matsumoto, Yasuyuki Kanke, Hisashi Onozawa, Suguru Hayase, Wataru Sakamoto, Teruhide Ishigame, Tomoyuki Momma, Shinji Ohki, and Seiichi Takenoshita. Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasis. Oncology Letters, December 2017. URL: http://dx.doi.org/10.3892/ol.2017.7559, doi:10.3892/ol.2017.7559. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2017.7559)

[2. (Cappello2018The) Anna Rita Cappello, Rosita Curcio, Rosamaria Lappano, Marcello Maggiolini, and Vincenza Dolce. The physiopathological role of the exchangers belonging to the slc37 family. Frontiers in Chemistry, April 2018. URL: http://dx.doi.org/10.3389/fchem.2018.00122, doi:10.3389/fchem.2018.00122. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fchem.2018.00122)

[3. (Pan2011SLC37A1) Chi-Jiunn Pan, Shih-Yin Chen, Hyun Sik Jun, Su Ru Lin, Brian C. Mansfield, and Janice Y. Chou. Slc37a1 and slc37a2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS ONE, 6(9):e23157, September 2011. URL: http://dx.doi.org/10.1371/journal.pone.0023157, doi:10.1371/journal.pone.0023157. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0023157)

[4. (Iacopetta2009SLC37A1) Domenico Iacopetta, Rosamaria Lappano, Anna Rita Cappello, Marianna Madeo, Ernestina Marianna De Francesco, Antonella Santoro, Rosita Curcio, Loredana Capobianco, Vincenzo Pezzi, Marcello Maggiolini, and Vincenza Dolce. Slc37a1 gene expression is up-regulated by epidermal growth factor in breast cancer cells. Breast Cancer Research and Treatment, 122(3):755â€“764, November 2009. URL: http://dx.doi.org/10.1007/s10549-009-0620-x, doi:10.1007/s10549-009-0620-x. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10549-009-0620-x)